Clearly, future studies should focus on directly comparing MGA271 scFv-based B7-H3-CARs with different costimulatory domains, including CD28, 41BB, and others, in this model to fully understand the different tumor control capacities of these CARs. The gene discussed is CD28; the disease is neoplasm.